Corporate DealsJun 2, 2025 · 4:22pm ET
KPRXKiora Pharmaceuticals, Inc. Common Stock
Kiora Pharmaceuticals Grants Senju Pharmaceutical Option to Develop and Market KIO-301 in Asia
Kiora Pharmaceuticals, Inc. has granted Senju Pharmaceutical Co., Ltd. an option to develop and market the vision-restoring drug KIO-301 in Asia.
Corporate DealsJun 2, 2025 · 4:22pm ET
KPRXKiora Pharmaceuticals, Inc. Common Stock+173.5%
Kiora Pharmaceuticals Grants Senju Pharmaceutical Option to Develop and Market KIO-301 in Asia